Cervical Pathology in High-Risk Human Papillomavirus-Positive, Cytologically Normal Women

  • Supho, Buasorn (Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University) ;
  • Supoken, Amornrat (Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University) ;
  • Kleebkaew, Pilaiwan (Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University) ;
  • Kietpeerakool, Chumnan (Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University)
  • Published : 2014.10.11


This study was undertaken to evaluate the prevalence of significant cervical pathology among women who are high-risk human papillomavirus (HR-HPV)-positive/cytology negative, the most common combination of positive co-tests. The records of 244 women HR-HPV-positive/cytology-negative who had undergone colposcopy at Srinagarind Hospital, Khon Kaen University during January 2010 and April 2014 were reviewed. Mean age was 46.4 years. Of these 224 women, 75 were positive for HPV types 16/18 (33.5%) and 123 were positive for non-16/18 types (54.9%). HR-HPV was not genotyped in the remaining 26 women (11.6%). Prevalence of significant lesions for the entire cohort was 2.4%, and 2.6% and 3.3%, respectively, for those with HPV 16/18 and other oncogenic HPV types. One woman with HPV 16/18 (1.3%) had invasive cervical cancer. Multiparous women were more likely to be infected with HPV 16/18 compared to nulliparous women (36.3% versus 17.6%, respectively). In conclusion, the prevalence of significant cervical lesion among our study population was 2.4%. Multiparous women were more likely to be infected with HPV 16/18 compared to nulliparous women.


  1. Hamzi Abdul Raub S, Isa NM, Zailani HA, et al (2014). Distribution of HPV genotypes in cervical cancer in multiethnic Malaysia. Asian Pac J Cancer Prev, 15, 651-6.
  2. Aue-Aungkul A, Punyawatanasin S, Natprathan A, et al (2011). "See and treat" approach is appropriate in women with highgrade lesions on either cervical cytology or colposcopy. Asian Pac J Cancer Prev, 12, 1723-6.
  3. Carozzi F, De Marco L, Gillio-Tos A, et al (2014). Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence. J Clin Virol, 60, 257-63.
  4. Castle PE, Fetterman B, Poitras N, et al (2009). Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol, 113, 595-600.
  5. Chiang YC, Cheng WF, Chen YL, et al (2013). High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions. Taiwan J Obstet Gynecol, 52, 222-6.
  6. de Sanjose S, Wheeler CM, Quint WG, et al (2013). Age-specific occurrence of HPV16- and HPV18-related cervical cancer. Cancer Epidemiol Biomarkers Prev, 22, 1313-8.
  7. Ingkapairoj N, Luanratanakorn S, Chumworathayi B, et al (2012). Incidences of cervical intraepithelial neoplasia 2-3 or cancer pathologic diagnoses in patients with a high grade squamous intraepithelial lesion pap smear attending a colposcopy clinic at srinagarind hospital. Asian Pac J Cancer Prev, 13, 6203-6.
  8. Kietpeerakool C, Cheewakriangkrai C, Suprasert P, et al (2009). Feasibility of the 'see and treat' approach in management of women with 'atypical squamous cell, cannot exclude high-grade squamous intraepithelial lesion' smears. J Obstet Gynaecol Res, 35, 507-13.
  9. Massad LS, Einstein MH, Huh WK, et al (2013). 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol, 121, 829-46.
  10. Siriaunkgul S, Utaipat U, Suwiwat S, et al (2012). Prognostic value of HPV18 DNA viral load in patients with early-stage neuroendocrine carcinoma of the uterine cervix. Asian Pac J Cancer Prev, 13, 3281-5.
  11. Natphopsuk S, Settheetham-Ishida W, Pientong C, et al (2013). Human papillomavirus genotypes and cervical cancer in northeast Thailand. Asian Pac J Cancer Prev, 14, 6961-4.
  12. Poomtavorn Y, Suwannarurk K, Thaweekul Y, et al (2011). Risk factors for high-grade cervical intraepithelial neoplasia in patients with atypical squamous cells of undetermined significance (ASC-US) Papanicolaou smears. Asian Pac J Cancer Prev, 12, 235-8.
  13. Saraiya M, Benard VB, Greek AA, et al (2014). Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies. Am J Obstet Gynecol, [Epub ahead of print].
  14. Sui S, Jiao Z, Niyazi M, et al (2013). Genotype distribution and behavioral risk factor analysis of human papillomavirus infection in Uyghur women. Asian Pac J Cancer Prev, 14, 5861-5.
  15. Suthipintawong C, Siriaunkgul S, Tungsinmunkong K, et al (2011). Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women. Asian Pac J Cancer Prev, 12, 853-6.
  16. Tabrizi SN, Brotherton JM, Stevens MP, et al (2014). HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program. J Clin Virol, 60, 250-6.
  17. Wiley DJ, Masongsong EV, Lu S, et al (2012). Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infections. Cancer Epidemiol, 36, 183-9.

Cited by

  1. Histologic Outcomes in HPV-Positive and Cervical Cytology-Negative Women - Screening Results in Northern Thailand vol.16, pp.16, 2015,
  2. High-grade Cervical Histopathology in Women with Atypical Glandular Cell Cytology vol.17, pp.1, 2016,
  3. The Importance of High-Risk Human Papillomavirus Types Other Than 16 and 18 in Cervical Neoplasia vol.142, pp.6, 2018,